By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Rosemont Pharmaceuticals Ltd. (Acquired By Bio-Technology General Corp.) 

Yorkdale Industrial Park; Rosemont House
Braithwaite Street
Leeds    LS11 9XE  United Kingdom
Phone: 44-113-2441400 Fax: 44-113-2460738



Company News
TLC Therapeutics Announces Multi-Product Licensing And Manufacturing Agreement With Rosemont Pharmaceuticals Ltd. (BTGC) 1/6/2017 7:52:16 AM
Perrigo Company (PRGO) Buys Rosemont Pharmaceuticals Ltd. (BTGC) for $283 Million 2/11/2013 7:18:12 AM
Rosemont Pharmaceuticals Ltd. (BTGC) Put Up for Sale With £200 Million Price Tag 9/25/2012 8:11:45 AM
Savient Pharmaceuticals, Inc. (SVNT) Completes Sale Of Rosemont Pharmaceuticals Ltd. (BTGC) Subsidiary For $176 Million 8/4/2006 1:35:16 PM
Savient Pharmaceuticals, Inc. (SVNT) Announces Exploration Of Strategic Alternatives For Rosemont Pharmaceuticals Ltd. (BTGC) Subsidiary Including Potential Spin Out Or Sale Of Business 2/17/2006 11:57:43 AM
Savient Pharmaceuticals, Inc. (SVNT) Submits New Drug Application For Soltamox To The U.S. FDA10/19/2005 5:11:56 PM
Savient Pharmaceuticals, Inc. (BTGC) Announces New Strategic Direction To Focus On Product Development; Company To Focus Resources On Clinical Development Of Its Two Phase II Products, Prosaptide And Puricase10/19/2005 5:09:00 PM